Holen Sie sich die Stockscreener-App
61.43
2.12%
1.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$60.14
Offen:
$58.81
24-Stunden-Volumen:
4.21M
Relative Volume:
0.73
Marktkapitalisierung:
$58.48B
Einnahmen:
$7.49B
Nettoeinkommen (Verlust:
$1.51B
KGV:
38.64
EPS:
1.59
Netto-Cashflow:
$1.62B
1W Leistung:
+2.27%
1M Leistung:
+5.43%
6M Leistung:
+13.43%
1J Leistung:
+11.25%
1-Tages-Spanne:
$58.62
$61.83
1-Wochen-Bereich:
$58.62
$61.83
52-Wochen-Spanne:
$43.32
$61.83
Monster Beverage Corp Stock (MNST) Company Profile
Firmenname
Monster Beverage Corp
Sektor
Branche
Telefon
909-739-6200
Adresse
1 MONSTER WAY, CORONA, CA
Vergleichen Sie MNST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
61.43 | 58.48B | 7.49B | 1.51B | 1.62B | 1.59 |
|
KO
Coca Cola Co
|
70.67 | 306.85B | 46.89B | 10.78B | -928.00M | 2.50 |
|
PEP
Pepsico Inc
|
130.69 | 183.11B | 91.52B | 9.37B | 7.27B | 6.80 |
|
KOF
Coca Cola Femsa S A B De C V Adr
|
93.44 | 19.54B | 15.24B | 1.29B | 0 | 6.1525 |
|
PRMB
Primo Brands Corp
|
32.11 | 12.38B | 0 | 0 | 0 | 0.00 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Bestätigt | Wells Fargo | Overweight |
| 2025-05-02 | Bestätigt | JP Morgan | Neutral |
| 2025-04-25 | Bestätigt | BofA Securities | Buy |
| 2025-04-23 | Bestätigt | Truist | Sell |
| 2025-04-17 | Bestätigt | UBS | Neutral |
| 2025-04-16 | Bestätigt | Jefferies | Buy |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-02 | Bestätigt | Wells Fargo | Overweight |
| 2025-03-03 | Bestätigt | UBS | Neutral |
| 2025-02-28 | Bestätigt | Citigroup | Buy |
| 2025-02-28 | Bestätigt | Deutsche Bank | Buy |
| 2025-02-28 | Bestätigt | JP Morgan | Neutral |
| 2025-02-28 | Bestätigt | Morgan Stanley | Overweight |
| 2024-12-19 | Bestätigt | Exane BNP Paribas | Underperform |
| 2024-12-06 | Eingeleitet | Needham | Hold |
| 2024-11-12 | Bestätigt | Argus | Buy |
| 2024-11-11 | Bestätigt | TD Cowen | Hold |
| 2024-11-08 | Bestätigt | Deutsche Bank | Buy |
| 2024-11-08 | Bestätigt | JP Morgan | Neutral |
| 2024-11-08 | Bestätigt | Stifel | Buy |
| 2024-11-08 | Bestätigt | UBS | Neutral |
| 2024-11-05 | Bestätigt | Wells Fargo | Overweight |
| 2024-11-04 | Bestätigt | JP Morgan | Neutral |
| 2024-10-15 | Bestätigt | BofA Securities | Buy |
| 2024-10-07 | Bestätigt | UBS | Neutral |
| 2024-08-12 | Bestätigt | ROTH MKM | Neutral |
| 2024-08-09 | Bestätigt | Truist | Sell |
| 2024-08-08 | Bestätigt | Citigroup | Buy |
| 2024-08-08 | Bestätigt | Deutsche Bank | Buy |
| 2024-08-08 | Bestätigt | JP Morgan | Neutral |
| 2024-08-08 | Bestätigt | Jefferies | Buy |
| 2024-08-08 | Bestätigt | Piper Sandler | Neutral |
| 2024-08-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2024-08-08 | Bestätigt | UBS | Neutral |
| 2024-08-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-23 | Bestätigt | JP Morgan | Neutral |
| 2024-07-15 | Bestätigt | TD Cowen | Hold |
| 2024-07-10 | Bestätigt | BofA Securities | Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-06-25 | Bestätigt | Wells Fargo | Overweight |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-06-17 | Bestätigt | Stifel | Buy |
| 2024-05-03 | Bestätigt | Morgan Stanley | Overweight |
| 2024-05-03 | Bestätigt | Piper Sandler | Neutral |
| 2024-05-03 | Bestätigt | UBS | Neutral |
| 2024-01-17 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-01-17 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Goldman | Buy |
| 2024-01-17 | Bestätigt | JP Morgan | Overweight |
| 2023-11-20 | Bestätigt | Piper Sandler | Neutral |
| 2023-11-20 | Bestätigt | ROTH MKM | Neutral |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-11-03 | Bestätigt | Wells Fargo | Overweight |
| 2023-10-31 | Bestätigt | JP Morgan | Overweight |
| 2023-10-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-10-23 | Bestätigt | Deutsche Bank | Buy |
| 2023-10-05 | Hochstufung | CFRA | Hold → Buy |
| 2023-08-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-08-10 | Bestätigt | ROTH MKM | Neutral |
| 2023-08-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | Bestätigt | UBS | Neutral |
| 2023-07-31 | Bestätigt | Stifel | Buy |
| 2023-07-25 | Bestätigt | Evercore ISI | Outperform |
| 2023-06-08 | Eingeleitet | Piper Sandler | Neutral |
| 2023-05-08 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-05-08 | Bestätigt | ROTH MKM | Neutral |
| 2023-05-05 | Bestätigt | BofA Securities | Buy |
| 2023-05-05 | Bestätigt | Citigroup | Buy |
| 2023-05-05 | Bestätigt | Deutsche Bank | Buy |
| 2023-05-05 | Bestätigt | Goldman | Buy |
| 2023-05-05 | Bestätigt | JP Morgan | Overweight |
| 2023-05-05 | Bestätigt | Morgan Stanley | Overweight |
| 2023-05-05 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-05-05 | Bestätigt | Truist | Buy |
| 2023-05-05 | Bestätigt | UBS | Neutral |
| 2023-05-05 | Bestätigt | Wells Fargo | Overweight |
| 2023-04-06 | Bestätigt | UBS | Neutral |
| 2023-04-06 | Bestätigt | Wedbush | Neutral |
| 2023-03-06 | Hochstufung | Redburn | Neutral → Buy |
| 2023-03-01 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-03-01 | Herabstufung | CFRA | Buy → Hold |
| 2023-03-01 | Bestätigt | Citigroup | Buy |
| 2023-03-01 | Bestätigt | JP Morgan | Overweight |
| 2023-03-01 | Bestätigt | Morgan Stanley | Overweight |
| 2023-03-01 | Bestätigt | Truist | Buy |
| 2023-03-01 | Bestätigt | Wells Fargo | Overweight |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-18 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-01-18 | Bestätigt | Evercore ISI | Outperform |
| 2022-11-04 | Bestätigt | BofA Securities | Buy |
| 2022-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2022-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-11-04 | Bestätigt | UBS | Neutral |
| 2022-11-04 | Bestätigt | Wells Fargo | Overweight |
| 2022-11-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-10-11 | Eingeleitet | Wedbush | Neutral |
| 2022-08-05 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-07-05 | Eingeleitet | ROTH Capital | Neutral |
| 2022-06-06 | Bestätigt | Morgan Stanley | Overweight |
| 2022-05-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-02-25 | Bestätigt | Citigroup | Buy |
| 2022-02-25 | Bestätigt | Cowen | Market Perform |
| 2022-02-25 | Bestätigt | Deutsche Bank | Buy |
| 2022-02-25 | Bestätigt | Guggenheim | Buy |
| 2022-02-25 | Bestätigt | JP Morgan | Neutral |
| 2022-02-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Eingeleitet | Redburn | Neutral |
| 2021-10-13 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-05-07 | Bestätigt | Truist | Buy |
| 2021-02-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2021-01-15 | Bestätigt | Citigroup | Neutral |
| 2021-01-15 | Bestätigt | Deutsche Bank | Buy |
| 2021-01-15 | Bestätigt | Truist | Buy |
| 2020-12-10 | Bestätigt | Morgan Stanley | Overweight |
| 2020-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-11-17 | Hochstufung | UBS | Sell → Neutral |
| 2020-11-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-20 | Bestätigt | Guggenheim | Buy |
| 2020-05-28 | Bestätigt | Stifel | Buy |
| 2020-05-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-05-05 | Bestätigt | Guggenheim | Buy |
| 2020-04-16 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-04-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-03-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-10-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-08 | Bestätigt | BMO Capital Markets | Market Perform |
| 2019-08-08 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2019-08-08 | Bestätigt | UBS | Sell |
| 2019-04-01 | Herabstufung | Macquarie | Outperform → Neutral |
| 2019-03-28 | Bestätigt | Morgan Stanley | Equal-Weight |
Alle ansehen
Monster Beverage Corp Aktie (MNST) Neueste Nachrichten
Monster's Q1 sales fall flat, but April fuels analyst optimism - MSN
Monster's Q1 sales fall flat, but April fuels analyst optimism (MNST:NASDAQ) - Seeking Alpha
Monster Beverage Stock Trades at All-Time High on Strong April Sales - MSN
Monster Beverage Faces Improving Margin Trends After Q1 Revenue Miss, Deutsche Bank Says - marketscreener.com
Monster Beverage's Margins Are Looking Healthier Despite Recent Hiccups - Finimize
Monster: Low-Energy Q1 Sees Net Sales Drop, Alcohol Drag - BevNET.com
Monster Beverage price target raised to $63 from $62 at UBS - TipRanks
Deutsche Bank Adjusts Monster Beverage Price Target to $68 From $66, Maintains Buy Rating - marketscreener.com
Monster Beverage Corporation (MNST) Earnings: 1Q25 Key Numbers - AlphaStreet
Morgan Stanley Raises Price Target on Monster Beverage to $65 From $60, Keeps Overweight Rating - marketscreener.com
Aptus Capital Advisors LLC Buys 6,926 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Crestline Management LP Acquires 5,913 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage Posts Surprise Fall In Quarterly Net Sales - European Supermarket Magazine
Monster Beverage Corp SEC 10-Q Report - TradingView
Monster Beverage Corp (MNST) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
The Manufacturers Life Insurance Company Sells 8,663 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster's CEO: 'We Don't Always Win' On Hedging—As Aluminum Tariffs Bite Into Q2 Margins - Benzinga
Monster Beverage (MNST) Sees Operating Income Rise Amid Q1 Sales Dip - GuruFocus
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast By Investing.com - Investing.com UK
Monster Beverage sees strong April sales growth with robust Q2 outlook - MSN
Monster Beverage Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Monster Beverage posts surprise fall in quarterly net sales on choppy demand - Reuters
Earnings call transcript: Monster Beverage misses Q1 2025 revenue forecast - Investing.com
Monster Beverage: Q1 Earnings Snapshot - The Washington Post
Monster (NASDAQ:MNST) Misses Q1 Revenue Estimates - Yahoo Finance
Monster Beverage sales slump on weak demand for alcohol beverages - MSN
Monster Beverage sales slump on weak demand for alcohol beverages (MNST:NASDAQ) - Seeking Alpha
Monster Beverage shares fall as Q1 results miss estimates By Investing.com - Investing.com Canada
Monster Beverage shares fall as Q1 results miss estimates - Investing.com
Monster Beverage earnings missed by $0.01, revenue fell short of estimates - Investing.com
Monster Beverage Corp Q1 2025 Earnings: EPS at $0.45 and Revenue at $1.85 Billion, Both Miss Estimates - GuruFocus
Monster Beverage Reports 2025 First Quarter Results - The Manila Times
Monster Beverage Q1 Adjusted Earnings Rise, Revenue Drops - marketscreener.com
Earnings Flash (MNST) Monster Beverage Reports Q1 Revenue $1.86B, vs. FactSet Est of $1.98B - marketscreener.com
Comerica Bank Sells 18,356 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Covenant Partners LLC Sells 5,754 Shares of Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage (NASDAQ:MNST) Hits New 52-Week High on Analyst Upgrade - MarketBeat
Caisse DE Depot ET Placement DU Quebec Has $31.82 Million Stock Holdings in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
Monster Beverage Co. (NASDAQ:MNST) Shares Sold by AQR Capital Management LLC - MarketBeat
Monster Beverage Gears Up for Q1 Earnings: Here's What You Should Know - MSN
McKesson, Monster Beverage, Expedia set to report earnings Thursday - Investing.com
RBC maintains Monster Beverage Outperform rating and $63 target - Investing.com
RBC maintains Monster Beverage Outperform rating and $63 target By Investing.com - Investing.com UK
Monster Beverage Co. (NASDAQ:MNST) Shares Purchased by Lido Advisors LLC - MarketBeat
Monster Beverage (NASDAQ:MNST) Given New $67.00 Price Target at Wells Fargo & Company - MarketBeat
Caxton Associates LP Takes Position in Monster Beverage Co. (NASDAQ:MNST) - MarketBeat
What To Expect From Monster’s (MNST) Q1 Earnings - Yahoo Finance
MONSTER BEVERAGE Earnings Preview: Recent $MNST Insider Trading, Hedge Fund Activity, and More - Nasdaq
This Stock Posted A New Record High Ahead Of Thursday’s Earnings Report - Barchart.com
Monster Beverage Stock: Short Report Risks vs Upside Potential - Investing.com
Evercore ISI Adjusts Monster Beverage Price Target to $65 From $60, Maintains Outperform Rating - marketscreener.com
Finanzdaten der Monster Beverage Corp-Aktie (MNST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):